Analyst Consensus ?
ConsensusBuy22 ratings
Bullish1881.8%
Neutral418.2%
Bearish00.0%
FN2 Earnings Intelligence
Axon Enterprise, Inc. complete analyst coverage
Axon Enterprise, Inc. (AXON) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$422.36Current
$300Low
$648.43Average
$900High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 26, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 20, 2026 |
| Argus Research | Buy | Buy | Maintain | Sep 3, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Needham | Buy | Buy | Maintain | Jul 6, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jun 25, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 8, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Feb 25, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Sep 29, 2025 |
| B of A Securities | Buy | Buy | Maintain | Aug 6, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 5, 2025 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Aug 5, 2025 |
| Craig-Hallum | Buy | Hold | Upgrade | Aug 5, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Feb 26, 2025 |
| Baird | Outperform | Outperform | Maintain | Dec 6, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 10, 2023 |
| Imperial Capital | In Line | In Line | Maintain | May 18, 2020 |
| Ladenburg Thalmann | Neutral | Buy | Downgrade | Oct 15, 2018 |
| CL King | Neutral | Buy | Downgrade | Mar 16, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $422.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $561 | $383.09 | +32.8% | Oct 20, 2026 |
| Raymond James | Analyst unavailable | $675 | $402.87 | +59.8% | Oct 15, 2026 |
| Argus Research | Analyst unavailable | $600 | $506.98 | +42.1% | Sep 3, 2026 |
| Morgan Stanley | Meta Marshall | $640 | $528.41 | +51.5% | Aug 6, 2026 |
| Goldman Sachs | Analyst unavailable | $715 | $561.47 | +69.3% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $732 | $551.4 | +73.3% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $688 | $609.49 | +62.9% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $724 | $565.8 | +71.4% | Jul 13, 2026 |
| Needham | Analyst unavailable | $750 | $597.04 | +77.6% | Jul 6, 2026 |
| Piper Sandler | James Fish | $674 | $457.33 | +59.6% | Jun 15, 2026 |
| Barclays | Tim Long | $523 | $426.89 | +23.8% | May 8, 2026 |
| Morgan Stanley | Analyst unavailable | $600 | $433.82 | +42.1% | May 7, 2026 |
| Goldman Sachs | Analyst unavailable | $535 | $434.5 | +26.7% | May 7, 2026 |
| UBS | Analyst unavailable | $440 | $416.57 | +4.2% | May 7, 2026 |
| Morgan Stanley | Analyst unavailable | $675 | $391.53 | +59.8% | Apr 8, 2026 |
| Goldman Sachs | Analyst unavailable | $625 | $391.53 | +48.0% | Apr 8, 2026 |
| Robert W. Baird | Analyst unavailable | $800 | $523.63 | +89.4% | Feb 25, 2026 |
| Craig-Hallum | Jeremy Hamblin | $820 | $543.47 | +94.1% | Feb 25, 2026 |
| RBC Capital | David Paige | $735 | $543.24 | +74.0% | Feb 25, 2026 |
| Piper Sandler | James Fish | $690 | $548.22 | +63.4% | Feb 25, 2026 |
| Northcoast Research | Keith Housum | $742 | $591.16 | +75.7% | Jan 6, 2026 |
| Morgan Stanley | Meta Marshall | $713 | $555.06 | +68.8% | Dec 17, 2025 |
| RBC Capital | Analyst unavailable | $860 | $554.37 | +103.6% | Nov 17, 2025 |
| Piper Sandler | James Fish | $753 | $622.38 | +78.3% | Nov 5, 2025 |
| Raymond James | Analyst unavailable | $855 | $867.12 | +102.4% | Aug 5, 2025 |
| Northland Securities | Michael Latimore | $800 | $867.12 | +89.4% | Aug 5, 2025 |
| Needham | Joshua Reilly | $870 | $867.12 | +106.0% | Aug 5, 2025 |
| UBS | Analyst unavailable | $840 | $867.12 | +98.9% | Aug 5, 2025 |
| Craig-Hallum | Analyst unavailable | $900 | $867.12 | +113.1% | Aug 5, 2025 |
| Morgan Stanley | Meta Marshall | $885 | $729.62 | +109.5% | Jul 11, 2025 |
| Barclays | Analyst unavailable | $726 | $506.96 | +71.9% | Feb 27, 2025 |
| Morgan Stanley | Meta Marshall | $700 | $636.39 | +65.7% | Dec 3, 2024 |
| Needham | Joshua Reilly | $525 | $443.98 | +24.3% | Oct 22, 2024 |
| Goldman Sachs | Michael Ng | $441 | $443.98 | +4.4% | Oct 22, 2024 |
| Robert W. Baird | William Power | $400 | $364.39 | -5.3% | Sep 10, 2024 |
| Craig-Hallum | Jeremy Hamblin | $370 | $315.35 | -12.4% | May 7, 2024 |
| Needham | Joshua Reilly | $400 | $311.27 | -5.3% | Apr 10, 2024 |
| Argus Research | John Staszak | $380 | $306.78 | -10.0% | Mar 13, 2024 |
| Credit Suisse | Sami Badri | $300 | $225.13 | -29.0% | Apr 11, 2023 |
| Morgan Stanley | Analyst unavailable | $155 | $168.59 | -63.3% | Dec 13, 2022 |
Track every rating change on AXON the moment it posts. Free to start.
Start freeGet the AXON recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.